WASHINGTON - Historically, the regulation of dietary supplements has been a significant challenge for the U.S. Food and Drug Administration (FDA), and the fact that some of these products are now being manufactured using nanotechnology creates an additional layer of complexity. This new report asks the question: Is FDA equipped to meet the emerging regulatory challenge of dietary supplements that use engineered nanomaterials? The short answer is no.